Pharmaceutical Preparations · DE · CIK 1356576
Develops and commercializes products for central nervous system diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 18, 2026: 7 sold $10.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Sell | 6,838 | $49.55 | $339K |
| Mar 18, 2026 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Sell | 412 | $50.48 | $21K |
| Mar 17, 2026 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Sell | 27,710 | $49.95 | $1.4M |
| Mar 17, 2026 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Sell | 22,290 | $50.73 | $1.1M |
| Mar 16, 2026 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Sell | 34,114 | $50.18 | $1.7M |
| Mar 16, 2026 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Sell | 15,886 | $50.49 | $802K |
| Mar 13, 2026 | Khattar Jack A.President, CEO | Sell | 24,138 | $50.09 | $1.2M |
| Mar 13, 2026 | Khattar Jack A.President, CEO | Sell | 10,742 | $51.00 | $548K |
| Mar 13, 2026 | Khattar Jack A.President, CEO | Sell | 120 | $51.75 | $6K |
| Mar 12, 2026 | Hudson Frederick M.Director | Sell | 5,369 | $50.61 | $272K |
| Mar 10, 2026 | Horich William ToddSVP, Commercial Operations | Sell | 4,439 | $55.00 | $244K |
| Mar 9, 2026 | Horich William ToddSVP, Commercial Operations | Sell | 4,438 | $54.00 | $240K |
| Mar 9, 2026 | Mottola FrankSVP, Chief Tech. Ops. Officer | Sell | 1,623 | $53.65 | $87K |
| Mar 6, 2026 | Gemayel GeorgesDirector | Sell | 8,787 | $53.00 | $466K |
| Mar 5, 2026 | Gemayel GeorgesDirector | Sell | 10,000 | $53.71 | $537K |
| Feb 19, 2026 | Sensenig BethanyDirector | Sell | 3,258 | $51.27 | $167K |
| Feb 19, 2026 | Sensenig BethanyDirector | Sell | 1,217 | $50.31 | $61K |
| Dec 19, 2025 | Mottola FrankSVP, Chief Tech. Ops. Officer | Sell | 15,000 | $50.47 | $757K |
| Dec 19, 2025 | Mottola FrankSVP, Chief Tech. Ops. Officer | Sell | 5,000 | $50.22 | $251K |
| Dec 18, 2025 | Bhatt Padmanabh P.Sr. VP of IP, CSO | Sell | 710 | $44.44 | $32K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.